Literature DB >> 2404481

Diabetic nephropathy. An update.

A S Reddi1, R A Camerini-Davalos.   

Abstract

Nephropathy is a serious microvascular complication in patients with insulin-dependent diabetes mellitus. In the United States, diabetes accounts for one fourth of new cases of end-stage renal disease each year. Complication rates and costs are much higher for diabetic than for nondiabetic patients with end-stage renal disease. Despite numerous studies, the pathophysiology of diabetic renal disease is not completely understood. We reviewed the current status of the structural, functional, biochemical, pathogenetic, and treatment modalities of diabetic renal disease and examined future therapeutic interventions.

Entities:  

Mesh:

Year:  1990        PMID: 2404481

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Effect of in vitro glucose and diabetic hyperglycemia on mouse kidney protein synthesis: relevance to diabetic microangiopathy.

Authors:  Silvia Iannello; Paolina Milazzo; Fabio Bordonaro; Francesco Belfiore
Journal:  MedGenMed       Date:  2005-09-07

Review 3.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

4.  The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes.

Authors:  R Klein; M D Knudtson; B E K Klein; B Zinman; R Gardiner; S Suissa; A R Sinaiko; S M Donnelly; P Goodyer; T Strand; M Mauer
Journal:  Diabetologia       Date:  2010-05-01       Impact factor: 10.122

Review 5.  Costs of insulin-dependent diabetes mellitus.

Authors:  T T Simell; H Sintonen; J Hahl; O G Simell
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

6.  Biosynthetic regulation of proteoglycans by aldohexoses and ATP.

Authors:  Y Kanwar; Y Yoshinaga; Z Liu; E Wallner; F Carone
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 7.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 8.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

9.  Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy.

Authors:  Kinnari Mistry; Kiran Kalia
Journal:  Indian J Clin Biochem       Date:  2009-07-09

10.  Incidence of microalbuminuria in tobacco chewers.

Authors:  Hitesh Shah
Journal:  Indian J Clin Biochem       Date:  2005-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.